X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-01-12 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $28.63 | -4,667 | 106,898 | -4% | -$133,616 | ||||||
2024-01-12 | INSM | Adsett Roger | COO | S - Sale | $28.63 | -5,251 | 148,559 | -3% | -$150,336 | ||||||
2024-01-09 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale | $28.78 | -1,861 | 113,829 | -2% | -$53,560 | ||||||
2024-01-09 | INSM | Smith Michael Alexander | GC, SVP | S - Sale | $28.76 | -2,373 | 86,364 | -3% | -$68,247 | ||||||
| D | 2024-01-09 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale+OE | $28.85 | -3,668 | 101,984 | -3% | -$105,831 | |||||
| M | 2024-01-09 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $28.99 | -5,960 | 111,565 | -5% | -$172,763 | |||||
2024-01-09 | INSM | Bonstein Sara | CFO | S - Sale | $29.18 | -4,497 | 114,051 | -4% | -$131,222 | ||||||
| M | 2024-01-09 | INSM | Adsett Roger | COO | S - Sale | $29.08 | -7,373 | 153,810 | -5% | -$214,423 | |||||
| DM | 2024-01-08 | INSM | Lewis William | Chair, CEO | S - Sale+OE | $29.32 | -55,007 | 598,075 | -8% | -$1,612,928 | |||||
| DM | 2024-01-03 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale+OE | $29.20 | -21,238 | 219,674 | -9% | -$620,089 | |||||
| D | 2024-01-05 | INSM | Smith Michael Alexander | GC, SVP | S - Sale+OE | $29.31 | -627 | 88,737 | -1% | -$18,374 | |||||
| D | 2024-01-05 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale+OE | $29.28 | -1,457 | 105,149 | -1% | -$42,661 | |||||
| D | 2024-01-05 | INSM | Lewis William | Chair, CEO | S - Sale+OE | $29.26 | -6,979 | 607,962 | -1% | -$204,195 | |||||
| D | 2024-01-05 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale+OE | $29.21 | -1,386 | 117,525 | -1% | -$40,478 | |||||
| D | 2024-01-05 | INSM | Adsett Roger | COO | S - Sale+OE | $29.21 | -3,042 | 161,183 | -2% | -$88,864 | |||||
| D | 2023-12-28 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale+OE | $32.00 | -22,288 | 94,549 | -19% | -$713,216 | |||||
| D | 2023-12-22 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale+OE | $30.00 | -28,310 | 106,038 | -21% | -$849,300 | |||||
2023-12-22 | INSM | Bonstein Sara | CFO | S - Sale | $30.00 | -13,199 | 105,241 | -11% | -$395,970 | ||||||
| D | 2023-10-27 | INSM | Lewis William | Chair, CEO | S - Sale+OE | $24.08 | -112,000 | 576,572 | -16% | -$2,696,449 | |||||
2023-07-11 | INSM | Smith Michael Alexander | GC, SVP | S - Sale | $20.18 | -740 | 77,142 | -1% | -$14,933 | ||||||
2023-06-13 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $19.27 | -8,868 | 106,038 | -8% | -$170,886 | ||||||
2023-06-13 | INSM | Adsett Roger | COO | S - Sale | $19.32 | -8,981 | 151,352 | -6% | -$173,513 | ||||||
2023-05-25 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale | $18.95 | -3,366 | 102,681 | -3% | -$63,786 | ||||||
| M | 2023-05-15 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale | $18.44 | -2,887 | 106,047 | -3% | -$53,224 | |||||
| M | 2023-05-15 | INSM | Smith Michael Alexander | GC, SVP | S - Sale | $18.77 | -3,635 | 77,082 | -5% | -$68,214 | |||||
| M | 2023-05-15 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale | $18.62 | -5,019 | 93,525 | -5% | -$93,438 | |||||
| M | 2023-05-15 | INSM | Lewis William | Chair, CEO | S - Sale | $18.58 | -16,861 | 575,269 | -3% | -$313,312 | |||||
| M | 2023-05-15 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $18.94 | -4,294 | 114,906 | -4% | -$81,328 | |||||
| M | 2023-05-15 | INSM | Bonstein Sara | CFO | S - Sale | $18.95 | -3,820 | 117,619 | -3% | -$72,390 | |||||
| M | 2023-05-15 | INSM | Adsett Roger | COO | S - Sale | $18.66 | -6,816 | 160,333 | -4% | -$127,191 | |||||
2023-05-15 | INSM | Sharoky Melvin Md | Dir | P - Purchase | $19.29 | +20,000 | 342,458 | +6% | +$385,800 | ||||||
2023-01-10 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale | $17.96 | -779 | 77,272 | -1% | -$13,991 | ||||||
2023-01-10 | INSM | Smith Michael Alexander | GC, SVP | S - Sale | $17.93 | -1,836 | 54,332 | -3% | -$32,919 | ||||||
2023-01-10 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale | $17.95 | -2,435 | 72,159 | -3% | -$43,708 | ||||||
2023-01-10 | INSM | Lewis William | Chair, CEO | S - Sale | $18.00 | -6,994 | 265,067 | -3% | -$125,892 | ||||||
2023-01-10 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $18.06 | -3,439 | 72,763 | -5% | -$62,108 | ||||||
2023-01-10 | INSM | Bonstein Sara | CFO | S - Sale | $18.12 | -2,857 | 66,031 | -4% | -$51,769 | ||||||
2023-01-10 | INSM | Adsett Roger | COO | S - Sale | $17.99 | -3,194 | 135,487 | -2% | -$57,460 | ||||||
| D | 2023-01-05 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale+OE | $19.74 | -1,160 | 78,051 | -1% | -$22,898 | |||||
| D | 2023-01-05 | INSM | Smith Michael Alexander | GC, SVP | S - Sale+OE | $19.72 | -720 | 56,168 | -1% | -$14,198 | |||||
| D | 2023-01-05 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale+OE | $19.73 | -1,448 | 74,594 | -2% | -$28,569 | |||||
| D | 2023-01-05 | INSM | Lewis William | Chair, CEO | S - Sale+OE | $19.80 | -7,008 | 272,061 | -3% | -$138,758 | |||||
| D | 2023-01-05 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale+OE | $19.73 | -1,374 | 76,202 | -2% | -$27,109 | |||||
| D | 2023-01-05 | INSM | Adsett Roger | COO | S - Sale+OE | $19.75 | -3,044 | 138,681 | -2% | -$60,119 | |||||
2022-11-22 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale | $18.84 | -7,154 | 71,613 | -9% | -$134,781 | ||||||
2022-11-22 | INSM | Adsett Roger | COO | S - Sale | $18.80 | -11,855 | 134,127 | -8% | -$222,874 | ||||||
| M | 2022-10-31 | INSM | Sharoky Melvin Md | Dir | P - Purchase | $17.59 | +30,000 | 301,552 | +11% | +$527,600 | |||||
2022-10-31 | INSM | Lee Leo | Dir | P - Purchase | $17.69 | +45,000 | 98,265 | +84% | +$796,050 | ||||||
2022-08-10 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale | $27.79 | -258 | 78,767 | 0% | -$7,170 | ||||||
| D | 2022-08-08 | INSM | Lewis William | Chair, CEO | S - Sale+OE | $27.84 | -216,800 | 256,716 | -46% | -$6,035,570 | |||||
2022-07-12 | INSM | Smith Michael Alexander | GC, SVP | S - Sale | $23.40 | -941 | 50,455 | -2% | -$22,019 | ||||||
| D | 2022-07-07 | INSM | Lewis William | Chair, CEO | S - Sale+OE | $23.00 | -96,614 | 256,716 | -27% | -$2,222,122 | |||||
| M | 2022-05-16 | INSM | Adsett Roger | COO | S - Sale | $19.57 | -3,416 | 145,982 | -2% | -$66,847 | |||||
2022-05-16 | INSM | Bonstein Sara | CFO | S - Sale | $18.51 | -1,433 | 54,683 | -3% | -$26,525 | ||||||
2022-05-16 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $18.51 | -1,574 | 66,432 | -2% | -$29,135 | ||||||
| M | 2022-05-16 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale | $19.53 | -2,784 | 68,822 | -4% | -$54,360 | |||||
| M | 2022-05-16 | INSM | Smith Michael Alexander | GC, SVP | S - Sale | $19.82 | -1,488 | 50,583 | -3% | -$29,492 | |||||
| M | 2022-05-16 | INSM | Lewis William | Chair, CEO | S - Sale | $19.52 | -9,394 | 255,828 | -4% | -$183,353 | |||||
2022-05-11 | INSM | Sharoky Melvin Md | Dir | P - Purchase | $17.20 | +20,000 | 265,652 | +8% | +$344,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |